PROJECT PLANS
AS Private Equity Limited group has several plans for the next future in some very appealing research and industrial sectors. Innovation and passion for new rousing exciting enterprises are always the keys of our work and the resulting companies reflect constantly this idea of exploration for the new.
Medicine - Metabolomic Research & Analisys
We are in the early stage of planning a revolutionary way to have personalized medicine. Studies and research are focused on Metabolomics and Longevity. Through sophisticate analysis, we aim to provide a unique innovative way to cure human diseases including chronic illness and to provide the best-personalized supplements and natural medicine. The research shall be based on the analysis made with the help of sophisticate "AI deep learning" applications to find the most accurate link discoveries of human deficiencies (in vitamin, minerals, protein, etc.) for assisting in the best personal health.
Our Metabolics Laboratories and Medical Clinique are planned to be started within 2023.
We aim to provide a wellness profile through the use of sophisticate analisys elaborated by our "Deep learning" software in-house systems, which would capitalize on the potential advantages of metabolomics for assessing health and wellness.
“Omics” Sciences and Metabolomics as a Revolutionary Tool
“Omics” involves the study of biological molecules, which translate into the function, structure, and dynamics of an organism or organisms. “Omics” is premised on characterizing and quantifying these molecules, so as to better understand how they contribute to organismal life. Different specializations exist within this broader “omics” term, including genomics, proteomics, and metabolomics.
​
Advantages of Metabolomics
Although both genomics and proteomics studies are advantageous in terms of analyses of organismal tissue samples and certain bodily fluids, they are generally more invasive than metabolomics studies. The advantage of metabolomics is that it can be performed using noninvasive biofluids, like plasma or urine. Additionally, metabolomics generally requires little sample preparation, which is advantageous in settings where rapid results of the metabolic profile are desired.
Furthermore, metabolomics, often conducted in preclinical settings, can provide valuable information to be translated into clinical studies, especially with regard to drug toxicity and disease/pre-disease condition studies. In fact, metabolomics has been used in some clinical settings, as in one study where urine samples were analyzed using metabolomics methods to determine the presence of renal cell carcinoma and its related biomarkers. Another study utilized metabolomics methods to detect coronary heart disease.
​
Metabolomics-Revolutionizing the Study of Diet Related Diseases
To expand on the value of metabolomics in studying health and wellness, one can refer to the slew of reviews commenting on metabolomics as a viable option for biomarker discovery. In the realm of diet-related research, metabolomics is utilized to improve the search for biomarkers that are implicated in the prognosis of diet-related diseases such as cardiovascular disease, diabetes, and some cancers. Furthermore, research indicates that metabolomics may be a key element in improving the early diagnosis of diseases and the accuracy of disease prognosis. It may also provide advantages in terms of monitoring diseases and determining early markers of damage to certain organs. Human-nutrition metabolomics has provided valuable insight on nutrient interactions with metabolism, as well as insight on the potential for metabolic alteration as a therapeutic intervention for improving health.
​
Wellness Profile
We aim to provide a wellness profile through the use of sophisticate analysis elaborated by our "AI Deep Learning" software in-house systems, which would capitalize on the potential advantages of metabolomics for assessing health and wellness. A non-invasive urinalysis and blood system measure specific biomarkers that are related to oxidative stress, inflammatory status, and antioxidant capacity. Our goal is to provide the best wellness analysis with valuable information to optimize health, wellness, and financial decision-making.
​
WellMetris extract page (copyright reserved to WellMetris)
​
​​Longevity
Metabolomics is also a very interesting field for longevity study. Why some people live much longer than others is an enduring mystery. Now, based on a study of a worm, scientists are getting one step closer to understanding longevity. They report in ACS' Journal of Proteome Research that the metabolic profiles of the worms could accurately predict how long they would live and that middle age could be a key turning point. To improve these predictions, researchers have started drawing from genetics, but DNA only tells part of the story. The researchers compared metabolic changes in normal worms with those of long-lived ones that had a genetic mutation. By profiling 26 metabolites, they could predict the worms' lifespans. We aim to use metabolomics and other studies (i.e. telomeres, etc.) to enhance our knowledge on these mechanisms for applications to human health in the next close future.
​
Health and Nutrition
Novel medications and formulas for pharmaceutical and cosmetics industries can be faster developed and improved through metabolomics. Studies can render new findings regarding the mode-of-action of specific compounds and monitor toxic by-product-accumulation and side-effects on the organism as well as identifying the best suitable personalized food supplements.
​
Deep Learning, AI, Neural Network, GA
Machine learning is one of the fastest-growing and most exciting fields out there, and deep learning represents its true bleeding edge. Neural networks and deep learning currently provide the best solutions to many problems in medicine and in particular in the medicine and health data processing getting results that would be impossible to reach with any other technology and in many medical areas, deep learning performs far better than human super-experts.
We have planned to establish some software laboratories specialized in "Deep Learning" using some special hardware platform (NVIDIA, etc.) and AI-Deep learning software to be applied to the medicine sector (and in particular to the metabolomic).
Our Deep Learning - AI Laboratories are planned to be started within 2023.
Data-Driven Medicine
​
All clinical diagnosis is based on data. Every time a doctor sees a patient, he is solving a complex data problem. Symptoms, patient history, lab test results, medical images, comparison with other patient cases, the list of possible diseases or ailments, the treatment options -- all of these are forms of data that must be remembered, understood, and integrated correctly. All clinical diagnosis is based on data.
​
There is a lot of medical data to comprehend. The first draft of the human metabolome has catalogued approximately 2500 metabolites, 1200 drugs and 3500 food components that can be found in the human body. This information, available at the Human Metabolome Database (www.hmdb.ca) and based on analysis of information available in the current scientific literature, is far from complete. Each type of cell and tissue has a unique metabolic ‘fingerprint’ that can elucidate organ or tissue-specific information, while the study of biofluids can give more generalized though less specialized information. Commonly used biofluids are urine and plasma, as they can be obtained non-invasively or relatively non-invasively, respectively. The ease of collection facilitates high temporal resolution, and because they are always at dynamic equilibrium with the body, they can describe the host as a whole. Unfortunately, much of this data is not being used to improve the diagnoses and treatments of patients. Deep Learning and AI software can strongly help to enhance the diagnoses output at a new level of quality and precision (i.e. "precision medicine") to a personalized level never experienced before.
​
Past attempts at data-driven medicine have been disappointingly limited. Medical interpretation programs have not lived up to their promise. They have suffered from a myriad of problems, including slow workflows, inadequate accuracy, and lack of scalability to handle vast amounts of data as well as the concept of personalized medicine is far to be achieved with the current medicine tools and knowledge. "Existing tools don't necessarily synthesize available data in a useful way to impact treatment paradigms," and it is not a surprise that many patients suffer from misdiagnoses - resulting in the unnecessary loss of health and losing the opportunity to live a longer life (up to 150 years) without diseases, especially chronic diseases.
​
Today we are on the cusp of an exciting revolution of improved healthcare. "Deep learning" software enables data-driven medicine at scale. Listed as one of MIT Tech Review's Top 10 Breakthroughs, deep learning has completely revolutionized how computers handle massive amounts of big data. Thanks to deep learning, computer performance is as on par with humans at some of the hardest tasks in medicine -- and performance continues to improve rapidly. We aim to implement synergically "deep learning" with medicine data in the metabolomics area with the final purpose to offer a very personalized health service both to people in good health for reaching optimal performance and for people with diseases for reestablishing and restoring their best health status.
Biotechnologies
Biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet.
We consider funding and/or entering in partnership in innovative biotechnology companies that fit our investment requirements.
At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet. We have used the biological processes of microorganisms for more than 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products. Modern biotechnology provides breakthrough products and technologies to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes
​
Currently, there are more than 250 biotechnology health care products and vaccines available to patients, many for previously untreatable diseases. More than 13.3 million farmers around the world use agricultural biotechnology to increase yields, prevent damage from insects and pests and reduce farming's impact on the environment.
​
Recent advances in biotechnology are helping us prepare for and meet society’s most pressing challenges.
​
Source: Healing, Fueling, Feeding: How Biotechnology is Enriching Your Life
Nanotechnologies
Nanotechnology is science, engineering, and technology conducted at the nanoscale. Nanoscience and nanotechnology IS THE NEW REVOLUTION that will change life and the economy drastically. We have projects for starting up some laboratories for making research in this sector for nano-products, new patents and future marketing planning.
We consider funding and/or entering in partnership in innovative nanotechnology companies that fit our investment requirements.
Over the course of the next 50 years, nanotechnology is set to advance our world beyond recognition. It will make our current technologies seem primitive and clunky. Soon, we will begin to see the effects of the first phase of this revolution.
​
Nanotechnology describes a wide variety of technologies and materials that share one thing in common: they are incredibly small in size, 10 thousand times too small to see. Typical nanostructures are the width of a strand of DNA (2 nanometers), 50 thousand times smaller than the width of a strand of hair.
​
The first phase of this revolution is already being seen in society. Passive nanostructures are what we are now seeing; structures that are designed to do one specific task. The most notorious structure is a new material called Graphene. It is described as a wonder material that will be as revolutionary as plastics, with its creators winning a Nobel Prize. It is 1 atom thick, transparent, a superconductor, harder, more flexible, lighter, and 300x stronger than steel, it is recyclable, sustainably manufacturable, eco-friendly and cost-effective in its use.
​
The Nanotechnology Revolution is also already in its second research and development stage. This next phase 2 will feature ‘Active Nanostructures’; ones that react with their environment to achieve certain tasks at the molecular level. Applications for this phase will, most excitingly, revolutionise health care. Examples include self-healing materials, targeted drugs and chemicals, sensors, and energy storage devices; they will sense and destroy cancer cells in our bodies.
​
​
Shipping & Naval Projects
We have funding projects in the naval & ships sector for the planning and construction of commercial ships in Europe and Asia.:
-
Ships for gas and oil transport (LNG vessels)
-
Acquisition, development and management of yachting ports/harbours.
​
This is one of the most advanced and important of our in-house current projects. We forecast to initiate the plan of construction of the first LNG (Liquid Natural Gas) vessel between the middle of 2023 and beginning of 2024. Business Plan available.
​
Alternative Energy
We invest in innovative alternative energy projects. Our project portfolio includes very innovative projects under the final stage of experimentation for forthcoming implementation.
We consider funding and/or entering in partnership in any interesting innovative project involving energy production that would fit our criteria.
​
Real Estate
We invest in Luxury and Prestigious Real Estate worldwide. Acquisition of properties can be linked to start-up enterprises or for property development involving Restaurants, Hotels, B&B, Resorts, Residentials, Condominium and others.
We consider funding and/or entering in partnership in any interesting innovative project involving Real Estate that would fit our criteria.
​
Biofuel Plant
We invest in innovative plants for production of biofuel, organic oil and bio-plastic. A first biofuel project is already planned and in progress to be developed by the end of 2023 and beginning of 2024. Business Plan available.
Other than our own biofuel projects, we consider to be involved in other external biofuel projects that would fit our criteria.